Trial Profile
An Observational, real-life study to assess the outcomes of Escitalopram treatment in patient suffering from Depression
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2017
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Depression
- Focus Adverse reactions; Therapeutic Use
- 11 Feb 2017 New trial record